Published online before print December 12, 2008

This Article Full Text (Rapid PDF) Supplemental Material All Versions of this Article: ajpath.2009.080522v1 174/1/256    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rooney, J. E. Articles by Burkin, D. J. Search for Related Content PubMed PubMed Citation Articles by Rooney, J. E. Articles by Burkin, D. J. Related Collections Related Article

Copyright © 2009 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2009.080522

Accepted for publication October 6, 2008.

Article

Laminin-111 Restores Regenerative Capacity in a Mouse Model for 7 Integrin Congenital Myopathy

Jachinta E. Rooney^*, Praveen B. Gurpur^*, Zipora Yablonka-Reuveni, and Dean J. Burkin^*@

From the Department of Pharmacology,* University of Nevada School of Medicine, Reno, Nevada; the Department of Biological Structure, University of Washington School of Medicine, Seattle, Washington; and the Nevada Transgenic Center, University of Nevada School of Medicine, Reno, Nevada

^@ To whom correspondence should be addressed. E-mail: dburkin{at}medicine.nevada.edu.

	Abstract

Mutations in the 7 integrin gene cause congenital myopathy characterized by delayed developmental milestones and impaired mobility. Previous studies in dystrophic mice suggest the 71 integrin may be critical for muscle repair. To investigate the role that 71 integrin plays in muscle regeneration, cardiotoxin was used to induce damage in the tibialis anterior muscle of 7 integrin-null mice. Unlike wild-type muscle, which responded rapidly to repair damaged myofibers, 7 integrin-deficient muscle exhibited defective regeneration. Analysis of Pax7 and MyoD expression revealed a profound delay in satellite cell activation after cardiotoxin treatment in 7 integrin-null animals when compared with wild type. We have recently demonstrated that the muscle of 7 integrin-null mice exhibits reduced laminin-2 expression. To test the hypothesis that loss of laminin contributes to the defective muscle regeneration phenotype observed in 7 integrin-null mice, mouse laminin-111 (1, 1, 1) protein was injected into the tibialis anterior muscle 3 days before cardiotoxin-induced injury. The injected laminin-111 protein infiltrated the entire muscle and restored myogenic repair and muscle regeneration in 7 integrin-null muscle to wild-type levels. Our data demonstrate a critical role for a laminin-rich microenvironment in muscle repair and suggest laminin- 111 protein may serve as an unexpected and novel therapeutic agent for patients with congenital myopathies.

This article has been cited by other articles:

				P. B. Gurpur, J. Liu, D. J. Burkin, and S. J. Kaufman Valproic Acid Activates the PI3K/Akt/mTOR Pathway in Muscle and Ameliorates Pathology in a Mouse Model of Duchenne Muscular Dystrophy Am. J. Pathol., March 1, 2009; 174(3): 999 - 1008. [Abstract] [Full Text] [PDF]